Pneumonie à pneumocoques

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
 
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.
 
Undefined

Vaccine in National Immunization Programme Update

WHO, UNICEF, and partners, are in regular dialogue with countries to support effective preparations.

Click here to access the downloadable PowerPoint file from the WHO website or simply click on the image below to read updates on vaccine in national immunization programmes.

Undefined

Central African Republic: MSF emergency team vaccinates 10,000 children against measles and pneumococcal disease

Médecins Sans Frontières (MSF) emergency teams have vaccinated almost 10,000 children in the Gadzi area of the Central African Republic, about 300 kilometres west of Bangui, after the appearance of several cases of measles led the local authorities to raise the alarm. The vaccination teams had to cope with major access problems due to the poor state of the roads and the dispersion of the population in the area, where more than 70,000 people live with virtually no basic healthcare.
 
Undefined

Pfizer partners with South Africa to produce pneumococcal vaccine

Global pharmaceutical company, Pfizer, has partnered with South Africa's Biovac Institute to produce a potentially life-saving pneumonia vaccine for infants, a cabinet minister said on Tuesday.
 
According to the World Health Organisation, pneumonia is the leading infectious cause of death among children worldwide, accounting for 15 percent of all deaths for children under the age of 5 years.
 
Undefined

Mali : Poliscopie : Paludisme, typhoïde, grippe…. la cote d’alerte est atteinte

Revers de la médaille cette bonne pluviométrie s’est accompagnée d’une explosion de maladies hydriques, paludisme et fièvre typhoïde en tête. Centres de santé, dispensaires et hôpitaux sont bondés de patients. Les assurances données par les spécialistes qui démentent l’entrée dans une phase d’épidémie tranche avec une réalité de terrain moins reluisante.
 
Undefined

Nepal earthquakes: How medics race to avert a health crisis

Three weeks, two earthquakes. More than 8,000 deaths and 17,000 injuries. Nearly 3 million displaced and more than 4 million people affected.

Nepal was brought tumbling down through a series of disasters beyond its control. The collapse of buildings may have ceased -- for now -- but the lives of Nepal's residents remain at risk with the deluge of health consequences now facing them.

Undefined

Human pneumonic plague outbreak has multiple transmission routes

According to a recent announcement from the Colorado Department of Public Health and Environment (CDPHE) laboratory, the recent outbreak of pneumonic plague can be transmitted from human to human as well as dog to human.
 
The laboratory identified and confirmed the presence of Yersinia pestis, which causes the plague, in a patient’s blood specimen. The man is currently hospitalized for pneumonia.
 
Undefined

MSF en campagne contre « l’injuste prix » de certains vaccins

Au début, le communiqué de presse daté de jeudi 23 avril – et la campagne de sensibilisation sur Twitter, avec le hashtag #AskPharma – se présente sous la forme d’un document caviardé. Des mots importants sont censurés par des bandeaux noirs, comme c’est le cas pour protéger des secrets industriels ou d’Etat. Une manière imagée pour Médecins sans frontières (MSF) d’appeler deux laboratoires pharmaceutiques producteurs de vaccins contre le pneumocoque, GlaxoSmithKline (qui commercialise le Synflorix) et Pfizer (Prevenar), à rendre public le prix de ce vaccin pour tous les pays.
Undefined

GSK responds to MSF's plea with pricing explanation--no discount

After urging price concessions for pneumococcal disease vaccines in January and receiving a 20-cent-per-dose discount from Pfizer ($PFE), Médecins Sans Frontières is sure to be unhappy with GlaxoSmithKline's ($GSK) response.
 
The British drugmaker issued a statement on Thursday explaining that the prices of its Synflorix are as low as possible and offered no discount.
 
Undefined

Immunization: Closing the gap on pneumonia in Kenya

Soon after the birth of her second child, a daughter she named Neema, Tabu Kalama found herself homeless and with no regular income. Ms Kalama had no option but to sleep with her newborn daughter and her 18-month old son in the meagre shelter of palm trees near the beach in Kilifi, in eastern Kenya.

Undefined

Pages